Harrison, C N, Nangalia, J, Boucher, R, Jackson, A, Yap, C, O'Sullivan, J, Fox, S, Ailts, I, Dueck, A C, Geyer, H L, Mesa, R A, Dunn, W G, Nadezhdin, E, Curto-Garcia, N, Green, A, Wilkins, B, Coppell, J, Laurie, J, Garg, M, Ewing, J, Knapper, S, Crowe, J, Chen, F, Koutsavlis, I, Godfrey, A, Arami, S, Drummond, M, Byrne, J, Clark, F, Mead-Harvey, C, Baxter, E J, McMullin, M F & Mead, A J 2023, ' Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial ', Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology . https://doi.org/10.1200/JCO.22.01935